Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-19T09:20:35.279Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of Persistent Myoclonic Tardive Dystonia with Verapamil

Published online by Cambridge University Press:  02 January 2018

Vincent Abad  and
Fred Ovsiew
Vincent Abad
Affiliation:
Boca Raton, Florida, USA
Fred Ovsiew*
Affiliation:
Clinical Neuropsychiatry, University of Chicago, 5841, South Maryland, Chicago, Illinois 60637, USA
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

A dramatic improvement in a patient with tardive dystonia was obtained with verapamil after the failure of other medicines. The use of verapamil or other calcium-channel blockers should be considered when treating drug-induced movement disorders.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 162 , Issue 4 , April 1993 , pp. 554 - 556
Copyright
Copyright © Royal College of Psychiatrists, 1993 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adler, L., Duncan, E., Reiter, S., et al (1988) Effects of calcium–channel antagonists on tardive dyskinesia and psychosis. Psychopharmacology Bulletin, 24, 421–425.Google Scholar
Borison, R. L., McLarnon, M. C., DeMartines, N., et al (1988) Calcium–channel antagonists: interaction with dopamine, schizophrenia, and tardive dyskinesia. In Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects (eds Wolf, M. E. & Mosnaim, A. D.), pp. 217–231. Washington, DC: American Psychiatric Press.Google Scholar
de Medina, A., Biasini, O., Rivera, A., et al (1986) Nifedipine and myoclonic dystonia. Annals of Internal Medicine, 104, 125.Google Scholar
Dick, R. S. & Barold, S. S. (1989) Diltiazem–induced parkinsonism. American Journal of Medicine, 87, 95–96.Google Scholar
Dubovsky, S. L., Franks, R. D. & Allen, S. (1987) Verapamil: a new antimanic drug with potential interactions with lithium. Journal of Clinical Psychiatry, 48, 371–372.Google ScholarPubMed
Falk, W. E., Wojick, J. D. & Gelenberg, A. J. (1988) Diltiazem for tardive dyskinesia and tardive dystonia. Lancet, i, 824–825.CrossRefGoogle Scholar
Kang, U. J., Burke, R. E. & Fahn, S. (1988) Tardive dystonia. Advances in Neurology, 30, 415–429.Google Scholar
Obeso, J. A., Rothwell, J. C., Lang, A. E., et al (1983) Myoclonic dystonia. Neurology, 33, 825–830.CrossRefGoogle ScholarPubMed
Snyder, S. H. & Reynolds, I. J. (1985) Calcium–antagonist drugs: receptor interactions that clarify therapeutic effects. New England Journal of Medicine, 313, 995–1002.Google Scholar
Walsh, T. L., Lavenstein, B., Licamele, W. L., et al (1986) Calcium–antagonists in the treatment of Tourette's disorder. American Journal of Psychiatry, 143, 1467–1468.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.